HomeIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
Nakaraang pagsara
$33.17
Sakop ng araw
$32.37 - $33.62
Sakop ng taon
$31.03 - $52.34
Market cap
5.15B USD
Average na Volume
1.63M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 133.81M | -7.21% |
Gastos sa pagpapatakbo | 259.28M | -2.73% |
Net na kita | -140.48M | 4.70% |
Net profit margin | -104.98 | -2.70% |
Kita sa bawat share | -0.72 | 14.35% |
EBITDA | -145.68M | -3.99% |
Aktuwal na % ng binabayarang buwis | 2.51% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.49B | 11.10% |
Kabuuang asset | 3.08B | 5.01% |
Kabuuang sagutin | 2.42B | -7.63% |
Kabuuang equity | 662.47M | — |
Natitirang share | 157.90M | — |
Presyo para makapag-book | 7.90 | — |
Return on assets | -12.88% | — |
Return on capital | -15.15% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -140.48M | 4.70% |
Cash mula sa mga operasyon | -114.99M | -5.47% |
Cash mula sa pag-invest | -340.80M | -595.98% |
Cash mula sa financing | 496.05M | 1,637.32% |
Net change in cash | 40.61M | 155.84% |
Malayang cash flow | -46.15M | 46.55% |
Tungkol
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza, Tegsedi, and Waylivra, and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.
The company was named Isis Pharmaceuticals until December 2015. Wikipedia
Itinatag
1989
Headquarters
Website
Mga Empleyado
927
